Spdr S&p Biotech Etf ETF Forecast

Buy or Hold candidate since Jun 11, 2026 Gain 20.88%

The SPDR S&P Biotech ETF price gained 2.50% on the last trading day (Thursday, 2nd Jul 2026), rising from $156.55 to $160.46. During the last trading day the ETF fluctuated 2.77% from a day low at $156.48 to a day high of $160.82. The price has risen in 8 of the last 10 days and is up by 15.12% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 2 million more shares were traded than the day before. In total, 9 million shares were bought and sold for approximately $1.47 billion.

The ETF has broken the wide and strong rising the short-term trend up and an even stronger rate of rising is indicated. For any reaction back there will now be support on the roof on the current trend broken at $152.11, a level that may pose a second chance to hit a runner. According to fan-theory $169.67 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

XBI Signals & Forecast

The SPDR S&P Biotech ETF holds buy signals from both short and long-term Moving Averages giving a positive forecast for the ETF. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $155.74 and $138.17. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Tuesday, May 19, 2026, and so far it has risen 26.56%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for SPDR S&P Biotech ETF

On the downside, the ETF finds support just below today's level from accumulated volume at $139.39 and $133.79. There is a natural risk involved when a ETF is testing a support level, since if this is broken, the ETF then may fall to the next support level. In this case, SPDR S&P Biotech finds support just below today's level at $139.39. If this is broken, then the next support from accumulated volume will be at $133.79 and $128.85.

This ETF may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this ETF is considered to be "high risk". During the last day, the ETF moved $4.34 between high and low, or 2.77%. For the last week, the ETF has had daily average volatility of 2.36%.

The SPDR S&P Biotech ETF is extremely overbought on RSI14 (92). Normally this may pose a good selling opportunity but since the ETF has broken the trend up, the chance for a major correction due to high RSI is very small as the ETF will find support at the trend broken.

Our recommended stop-loss: $155.39 (-3.16%) (This ETF has high daily movements and this gives high risk. The RSI14 is 92 and this increases the risk substantially. There is a buy signal from a pivot bottom found 30 days ago.)

Trading Expectations (XBI) For The Upcoming Trading Day Of Monday 6th

For the upcoming trading day on Monday, 6th we expect SPDR S&P Biotech ETF to open at $159.25, and during the day (based on 14 day Average True Range), to move between $158.42 and $162.50, which gives a possible trading interval of +/-$4.08 (+/-2.57%) up or down from last closing price. If SPDR S&P Biotech ETF takes out the full calculated possible swing range there will be an estimated 2.57% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $139.39, some $21.07 (13.13%) from the current price of $160.46, our system finds the risk reward attractive.

Is SPDR S&P Biotech ETF ETF A Buy?

SPDR S&P Biotech holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this ETF since the last evaluation from a Buy to a Hold candidate.

Current score: 0.000 Hold/Accumulate Downgraded

Zero in score indicates that our system is expecting high volatility and risk for the following trading day. Given the latest developments, we cannot determine the next direction as it may go both ways.

Predicted Fair Opening Price

Predicted fair opening price on July 6, 2026 - $159.25 ( 0.752%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk